Abstract
Background
Treatment-resistant depression (TRD) poses a significant challenge, with electroconvulsive therapy (ECT) being its highly effective intervention. The choice of anesthetic agents may influence the treatment efficacy and outcomes. This meta-analysis compares ketamine and thiopental as anesthetic adjuvants during ECT in TRD patients.
Methods
A systematic review and meta-analysis were performed, including four studies with 320 participants selected from six databases. The included studies comprised three randomized controlled trials (RCTs) and one retrospective cohort study. Outcomes analyzed using RevMan 5.4, which included HDRS or HAM-D scores, seizure duration, cognitive outcomes, and adverse events. Data were assessed using a random-effects model, with heterogeneity evaluated via the I2 statistic.
Results
Both ketamine and thiopental significantly reduced depressive symptoms (ketamine: MD 22.19, 95% CI [16.99, 27.40], P < 0.001; thiopental: MD 20.24, 95% CI [14.07, 26.41], P < 0.001). No significant differences were observed in their efficacy for symptom reduction (SMD −0.43, 95% CI [−0.99, 0.12], P = 0.12) or seizure duration (SMD 0.28, 95% CI [−0.50, 1.06], P = 0.48). Ketamine showed longer EEG seizure durations, indicating potential enhancement of ECT effectiveness, but it was associated with higher rates of nausea, transient delirium, and hypertension. Thiopental had a more favorable safety profile for patients with cardiovascular comorbidities. Cognitive outcomes varied, with mixed findings across studies. Significant heterogeneity was observed.
Conclusion
Both ketamine and thiopental are equally effective as ECT adjuvants in TRD patients. Further research with larger sample sizes, standardized protocols, and subgroup analyses is needed to confirm its superiority and address the heterogeneity.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
